Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer

Journal of Epidemiology and Community Health

Volumn 61, Issue 7, 2007, Pages 641-649

  Morales, Eva ^b,c,i   Porta, Miquel ^a,b,c,i   Vioque, Jesús ^d   López, Tomàs ^b,c   Mendez, Michelle A ^b,c   Pumarega, José ^b,c   Malats, Núria ^b,c   Crous Bou, Maria ^a,b,c   Ngo, Joy ^b,c   Rifà, Juli ^e   Carrato, Alfredo ^f   Guarner, Luisa ^a,g   Corominas, Josep M ^a,h   Real, Francisco X ^b,c,i  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f Hospital Universitari d'Elx   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL DEL MAR   (Spain)

ⁱ UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

CANCER; DIET; FOOD INTAKE; MILK; MUTATION; NUTRITION; QUESTIONNAIRE SURVEY;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BUTTER; CALORIC INTAKE; CANCER INCIDENCE; CANCER RISK; COFFEE; CONFIDENCE INTERVAL; DAIRY PRODUCT; EXOCRINE PANCREATIC CANCER; FEMALE; FOOD INTAKE; HOSPITAL ADMISSION; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MILK; ONCOGENE K RAS; PANCREAS CANCER; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SMOKING; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOOD; GENES, RAS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SPAIN;

ORA;

EID: 34347239682     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2007.060632     Document Type: Article

References (73)

1. Li D, Jiao L, Porta M. Epidemiology. In: von Hoff DD, Evans DB, Hruban RH, eds. Pancreatic cancer. Boston: Jones & Bartlett, 2005:103-117.
2. Soliman AS, Bondy M, Webb CR, et al. Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients. Int J Cancer 2006;119:1455-61.
3. Porta M, Ayude D, Alguacil J, et al. Exploring environmental causes of altered ras effects: fragmentation plus integration? Mol Carcinog 2003;36:45-52.
4. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002;2:897-909.
5. Howe GR, Ghadirian P, Bueno de Mesquita HB, et al. A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme. Int J Cancer 1992;51:365-72.
6. Howe GR, Burch JD. Nutrition and pancreatic cancer. Cancer Causes Control 1996;7:69-82.
7. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999;91:535-41.
8. Skinner HG, Michaud DS, Giovannucci E, et al. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006;15:1688-95.
9. Stolzenberg-Solomon RZ, Vieth R, Azad A, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 2006;66:10213-9.
10. Porta M, Malats N, Jariod M, et al. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. Lancet 1999;354:2125-9.
11. Real FX. The cell biology of pancreatic cancer. In: Neoptolemos J, Lemoine NR, eds. Pancreatic cancer.Molecular and clinical advances. London: Blackwell, 1995:3-17.
12. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003;3:459-65.
13. Shields JM, Pruitt K, McFall A, et al. Understanding Ras: "it ain't over 'til it's over". Trends Cell Biol 2000;10:147-54.
14. Alguacil J, Porta M, Malats N, et al. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer. Carcinogenesis 2002;23:101-6.
15. Porta M, Malats N, Guarner L, et al. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health 1999;53:702-9.
16. Porta M, Malats N, Alguacil J, et al. Coffee, pancreatic cancer, and K-ras mutations: updating the research agenda. J Epidemiol Community Health 2000;54:656-9.
17. Slebos RJ, Hoppin JA, Tolbert PE, et al. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomark Prev 2000;9:1223-32.
18. Jacobsen BK, Heuch I. Coffee, K-ras mutations and pancreatic cancer: a heterogeneous aetiology or an artefact? J Epidemiol Community Health 2000;54:654-5.
19. Bautista D, Obrador A, Moreno V, et al. Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997;6:57-61.
20. Kampman E, Voskuil DW, van Kraats AA, et al. Animal products and K-ras codon 12 and 13 mutations in colon carcinomas. Carcinogenesis 2000;21:307-9.
21. Slattery ML, Curtin K, Anderson K, et al. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Res 2000;60:6935-41.
22. Laso N, Mas S, Lafuente JM, et al. Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation. Anticancer Res 2004;24:2011-20.
23. Brink M, Weijenberg MP, de Goeij AF, et al. Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. Int J Cancer 2005;114:824-30.
24. Brink M, Weijenberg MP, de Goeij AF, et al. Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. Br J Cancer 2005;92:1310-20.
25. Martinez ME, Maltzman T, Marshall JR, et al. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res 1999;59:5181-5.
26. Work PA, Van der Kuil W, Ploemacher J, et al. Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas. Int J Cancer 2006;119:398-405.
27. Yano T, Uchida M, Yuasa M, et al. The inhibitory effect of vitamin E on K-ras mutation at an early stage of lung carcinogenesis in mice. Eur J Pharmacol 1997;323:99-102.
28. Mendez MA, Vioque J, Porta M, et al. Estimating dietary intakes from a brief questionnaire: A simulation study of reliability in a molecular epidemiologic study of pancreatic and biliary diseases. Eur J Epidemiol 2006;21:417-26.
29. Porta M, Fabregat X, Malats N, et al. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol 2005;7:189-97.
30. Gavaldà L, Porta M, Malats N, et al. Concordancia entre la información facilitada por el paciente y un familiar sobre antecedentes patológicos, consumo de tabaco, de alcohol, de café, y dieta en el cáncer de páncreas exocrino y del sistema biliar extrahepático. Gac Sanit 1995;9:334-42.
31. Vioque J, González L. Validity of a food frequency questionnaire. Preliminary results. Eur J Cancer Prev 1991;1:19-20.
32. Rosenbaum PR. The case-only odds ratio as a causal parameter. Biometrics 2004;60:233-40.
33. Willett WC, Stampfer M. Implications of total energy intake for epidemiologic analyses. In: Willett WC, eds. Nutritional epidemiology. 2nd ed. New York: Oxford University Press, 1998:273-301.
34. Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. 4th edn. Oxford: Blackwell, 2002.
35. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. Belmont, CA: Lifetime Learning Publications, 1982;320-76,343,419-56.
36. Breslow NE, Day NE. Statistical methods in cancer research. Vol I: The analysis of case-control studies. Lyon: IARC Scientific Publications, 1980:149-54.
37. Porta M, Jariod M, Lopez T, et al. In pancreatic ductal adenocarcinoma coffee intake and serum concentrations of some organochlorine compounds are independently associated with the mutational activation of the K-ras oncogene [abstract]. Fifth AACR International Conference on Frontiers in Cancer Prevention Research (Boston, Nov. 12-15, 2006). AACR Meeting Abstracts;2006:A187. Available from http://www.aacrmeetingabstracts.org/ [date accessed 3 March 2007].
38. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, et al. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002;155:783-92.
39. Falk RT, Pickle LW, Fontham ET, et al. Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol 1988;128:324-36.
40. Michaud DS, Giovannucci E, Willett WC, et al. Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. Am J Epidemiol 2003;157:1115-25.
41. Nöthlings U, Wilkens LR, Murphy SP, et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst 2005;97:1458-65.
42. Institute of Medicine. Dioxins and dioxin-like compounds in the food supply. Strategies to decrease exposure. Washington, DC: The National Academies Press, 2003.
43. Kalantzi OI, Alcock RE, Johnston PA, et al. The global distribution of PCBs and organochlorine pesticides in butter. Environ Sci Technol 2001;35:1013-8.
44. Weiss J, Papke O, Bergman A. A worldwide survey of polychlorinated dibenzo-p-dioxins, dibenzofurans, and related contaminants in butter. Ambio 2005;34:589-97.
45. Santillo D, Fernandes A, Stringer R, et al. Butter as an indicator of regional persistent organic pollutant contamination: further development of the approach using polychlorinated dioxins and furans (PCDD/Fs), and dioxin-like polychlorinated biphenyls (PCBs). Food Addit Contam 2003;20:281-90.
46. Badia-Vila M, Ociepa M, Mateo R, et al. Comparison of residue levels of persistent organochlorine compounds in butter from Spain and from other European countries. J Environ Sci Health B 2000;35:201-10.
47. Abad E, Llerena JJ, Saulo J, et al. Study on PCDDs/PCDFs and co-PCBs content in food samples from Catalonia (Spain). Chemosphere 2002;46:1435-41.
48. Eliarrat E, Monjonell A, Caixach J, et al. Toxic potency of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and polychlorinated biphenyls in food samples from Catalonia (Spain). J Agric Food Chemistry 2002;50:1161-7.
49. Bocio A, Domingo JL. Daily intake of polychlorinated dibenzo-p-dioxins/polychlorinated dibenzofurans (PCDD/PCDFs) in foodstuffs consumed in Tarragona, Spain: a review of recent studies (2001-2003) on human PCDD/PCDF exposure through the diet. Environ Res 2005;97:1-9.
50. Schafer KS, Kegley SE. Persistent toxic chemicals in the food supply. J Epidemiol Community Health 2002;56:813-7.
51. Ribas-Fitó N, Torrent M, Carrizo D, et al. In utero exposure to background concentrations of DDT and cognitive functioning among preschoolers. Am J Epidemiol 2006;164:955-62.
52. Carreno J, Rivas A, Granada A, et al. Exposure of young men to organochlorine pesticides in Southern Spain. Environ Res 2007;103:55-61.
53. Hoppin JA, Tolbert PE, Holly EA, et al. Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomark Prev 2000;9:199-205.
54. Porta M, Malats N, Vioque J, et al. Incomplete overlapping of biological, clinical and environmental information in molecular epidemiologic studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health 2002;56:734-8.
55. Kuper HE, Mucci LA, Trichopoulos D. Coffee, pancreatic cancer and the question of causation. J Epidemiol Community Health 2000;54:650-51.
56. Vineis P. ras mutations and a cup of coffee: cause, confounder, effect modifier, or what else? [editorial]. J Epidemiol Community Health 1999;53:685.
57. Vineis P. Exposures, mutations and the history of causality. J Epidemiol Community Health 2000;54:652-3.
58. Porta M, Vioque J, Ayude D, et al. Coffee drinking: The rationale for treating it as a potential effect modifier of carcinogenic exposures. Eur J Epidemiol 2003;18:289-98.
59. Luch A. Nature and nurture. Lessons from chemical carcinogenesis. Nat Rev Cancer 2005;5:113-25.
60. Kakiuchi H, Ushijima T, Ochiai M, et al. Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: possible alternative mechanisms of human colon carcinogenesis. Mol Carcinog 1993;8:44-8.
61. Toyota M, Ushijima T, Kakiuchi H, et al. Genetic alterations in rat colon tumors induced by heterocyclic amines. Cancer 1996;77(8 Suppl):1593-7.
62. Ushijima T, Kakiuchi H, Makino H, et al. Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol Carcinog 1994;10:38-44.
63. Hass BS, Hart RW, Lu MH, et al. Effects of caloric restriction in animals on cellular function, oncogene expression, and DNA methylation in vitro. Mutat Res 1993;295:281-9.
64. Fernandes G, Chandrasekar B, Troyer DA, et al. Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc Natl Acad Sci USA 1995;92:6494-8.
65. Fujii H, Egami H, Chaney W, et al. Pancreatic ductal adenocarcinomas induced in Syrian namsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog 1990;3:296-301.
66. Roebuck BD. Dietary fat and the development of pancreatic cancer. Lipids 1992;27:804-6.
67. Woutersen RA, Appel MJ, van Garderen-Hoetmer A, et al. Dietary fat and carcinogenesis. Mutat Res 1999;443:111-27.
68. Collett ED, Davidson LA, Fan YY, et al. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 2001;280:C1066-75.
69. Liu G, Bibus DM, Bode AM, et al. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc Natl Acad Sci USA 2001;98:7510-5.
70. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res 1997;57:253-8.
71. Roynette CE, Colder PC, Dupertuis YM, et al. n-3 polyunsaturated fatty acids and colon cancer prevention. Clin Nutr 2004;23:139-51.
72. Larsson SC, Kumlin M, Ingelman-Sundberg M, et al. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004;79:935-45.
73. Porta M, Malats N, Corominas JM, et al. Generalizing molecular results arising from incomplete biological samples: expected bias and unexpected findings. Ann Epidemiol 2002;12:7-14.